businessfortnight

Ahmed (name changed) from Bangladesh a 22-year-old doing his Bachelors in Law was diagnosed with a condition called Avascular necrosis of the right femoral head. A condition which occurs due to poor blood supply to the femoral head. The problem started a year ago, when he had complained that he had unbearable progressive pain in his right hip. The pain which went on for a year not only had affected his daily routine but his athletic career and his education also. Avascular Necrosis commonly affects youngsters and is most often due to bone dislocations, fractures, alcoholism and longstanding usage of steroids for medical conditions. Even though the exact reason for this condition is still not known but the region most commonly affected is the femoral head. As the head of femur progressively get damaged until the head finally collapses leading to severe pain.He was advised a total hip replacement at his hometown but was reluctant due to his age, limitation of his athletic activities and

JCB India launches its new 3DX ecoXPERT Designed to give significant savings in Fuel and Maintenance Integrated with “IntelliPerformance” India’s leading manufacturer of Earthmoving and Construction Equipment, JCB India launched its all new 3DX ecoXPERT Backhoe Loader in Bhopal.With JCB’s ‘IntelliPerformance’ technology, which efficiently manages the energy demands of the machine, the intelligent new 3DX ecoXPERT saves fuel and reduces maintenance costs, thus leading to significant savings.Mr. Subir Kumar Chowdhury, Managing Director & CEO of JCB India says, “We are delighted to have launched our new Backhoe Loader, the 3DX ecoXPERT. This new machine is designed to give up to 12% savings on fuel and up to 22% savings on maintenance. Equipped with ‘IntelliPerformance’ technology the machine comes with advanced telematics called JCB Livelink which enables real-time fleet management of equipment for our customers. JCB has pioneered in integrating Smart technologies such as Internet o

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo ® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).“This launch is a testament to our core strengths in areas of research and development and intellectual property,” says Marc Kikuchi, Chief Executive Officer, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo ®  Tablets and to provide an affordable treatment alternative for patients.” The Vimovo ® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December 2019 according to IQVIA Health*.Dr. Reddy’s Naproxen and Esome

The leading real estate consultant, Investors Clinic opened its new office in Doha, Qatar after remarkable success in Dubai & Singapore. The Qatar branch will expand Investors Clinic’s business further by increasing its foot-print globally. A promising and leading player of the Real Estate Industry – Investors Clinic has taken real-estate consultancy industry to newer heights. As a leading real estate advisory, IC has been credited with various technological firsts like introduction of Artificial Intelligence (AI) and Machine Learning enabled technology in real estate. On the recent launch of Doha operations, Honeyy Katiyal, Founder of Investors Clinic said, “After eminent footprint in India, Singapore and Dubai, we are looking forward to replicate the successful and proven IC business model and create a positive & profitable impact in Doha. We expect to further enhance the interest of NRIs in the Indian real estate Industry. Within the first year we plan to target a sizeable

A diagnosis of cancer is more often than not a sentinel event in someone’s lifetime. There are several challenges to be faced in such an event like choosing the right treatment, dealing with side effects, absence from social life, financial constraints and family issues including challenges for the caregivers. The most important risk factor for getting cancer is age and most patients in any oncologist’s OPD belong to the elderly population. The management of cancer does not stop at just giving chemotherapy. Incorporation of latest diagnostic and treatment modalities along with a more holistic approach for all round wellbeing is needed. Mrs Prathiba (name Changed) 69-year-old lady was diagnosed with a type of blood cancer called Multiple Myeloma in 2014. Multiple Myeloma is a disease with a unique set of challenges like exacerbation of age-related bone degeneration, weakness due to low blood haemoglobin levels and kidney dysfunction. She was initially treated with a combination of chem

Over the years, mutual funds have seen massive growth in the Indian market, which has resulted in the myriad options for the people in the form of best mutual funds to invest. There are various systems that judge it such as Morning Star, CRISIL, ICRA. They consider various quantitative and qualitative factors to select the best mutual funds to invest. These factors include returns, asset size, Standard Deviation, expense ratio, and more. After evaluating each of the factors mentioned, the results are added and the final results are declared. Before having a look at some of the best mutual funds to invest , let’s discuss why one should invest in mutual funds. Here are some of the solid reasons why you should invest in mutual funds: It is an open-ended scheme, which means it is hassle-free to buy or close a scheme. It holds various financial tools to invest in such as fixed income instruments, stocks, gold, and more. This allows you to enjoy the advantages of diversification just by inv

Continuing its concerted efforts towards fighting cancer, Apollo Hospitals & CURE Foundation India, India’s foremost healthcare provider will be hosting 5 th  Edition of APOLLO CANCER CONCLAVE (ACC) and the 8 th  Edition of the CANCER CI 2020, an international conference aimed at improving cancer management in India and abroad. To be held from 13 th  to 16 th February 2020, at HICC, this forum of International repute will witness participation by over 3500 delegates including 60 from overseas and over 600 faculty including 31 top-notch International Guest Speakers, eminent researchers and medical practitioners. Dr. P Vijay Anand Reddy, Director, Apollo Cancer Institutes, Hyderabad & Chairman, Org. Committee – CANCER CI – 2020; Dr Stefan Glueck, Medical Oncology, Summit, NJ, USA; Dr Steven H. Lin, Radiation Oncology, Houston, TX, USA; Dr Sangeeta Kakoti, Nuclear Medicine, Gunma, Japan; Dr S.V.S.S. Prasad, Medical Oncology, ACI, Hyderabad; Dr M. Vamshi Krishna, Medical Oncology